Media type
1:31:28
Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR (S9)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 9 from the 4th World Sepsis Congress. To go directly to a specific speak...
Media type
1:47:41
An Update on Research on Sepsis (Session 16 – 4th World Sepsis Congress)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 16 from the 4th World Sepsis Congress. To go directly to a specific spea...
Media type
1:14:28
Harnessing the Media to Advance the Global Fight Against Sepsis (Session 15 – 4th WSC)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 15 from the 4th World Sepsis Congress. To go directly to a specific spea...
Media type
1:32:18
Maternal Sepsis: Why Is It Still in the Top 3 for Global Incidence of Sepsis? (Session 14 – 4th WSC)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 14 from the 4th World Sepsis Congress. To go directly to a specific spea...
Media type
1:15:55
The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy (S13 – 4th WSC)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 13 from the 4th World Sepsis Congress. To go directly to a specific spea...
Media type
1:21:03
Understanding and Improving Long-term Outcomes after Sepsis and COVID-19 (Session 11 – 4th WSC)
0 0
by Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv 3 months ago
Session 11 from the 4th World Sepsis Congress. To go directly to a specific spea...

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.